Chemical structure of Remdesivir, one of the items for which fraudsters are conning Indians out of money. Image credit: Hbf878, CC0, via Wikimedia Commons By Nicholas Parry India’s plight amidst the second wave of COVID-19 is dire. The death toll is rising and there is still no end in sight to the rise in cases. Many …
On April 5th, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic. Two days later marked World Health Day. In 2021, World Health Day occurs once more against the backdrop of the COVID-19 pandemic. At the time Health Issues India covered World Health Day last year, I wrote “India [had] reported thousands …
World Health Day in a time of global crisis – again Read More »
The Indian government has been asked to increase efforts to tackle rare diseases by March 31st by the Delhi High Court. Millions of people may be living with more than 7,000 illnesses categorised as rare diseases across India. With this in mind, the government has been asked to finalise and operationalise progressive policy implementation that involves …
Delhi High Court asks Indian government to provide greater focus on rare disease Read More »
Research has shone a light on “long COVID” symptoms, identifying stroke, chest pain, and blood clot-related complications as among the most serious adverse effects patients experience after recovery. Review authors of the study, published in Nature Medicine, highlighted the plight of so-called ‘COVID long-haulers’. “We felt that a review of all these possible issues would …
Every Indian aged 45 and above will be eligible to receive a COVID-19 vaccine as of April 1st, the Government has said. Government minister Prakash Javadekar briefed reporters on the development following a meeting of the Union Cabinet chaired by Prime Minister Narendra Modi. Javadekar urged vaccine uptake, stating “I urge all above the age …
COVID-19 vaccines for all above 45 from April 1st, Govt. says Read More »
Both the Indian government and the World Health Organization (WHO) have addressed recent concerns surrounding the Oxford University/AstraZeneca COVID-19 vaccine and blood clots. Recent days saw multiple nations in Europe suspend use of the vaccine in their inoculation programmes as a precautionary measure. France, Germany, Italy, and Spain are among the countries to have taken …
AstraZeneca vaccine blood clots concerns addressed by Indian Government and WHO Read More »
Subrahmanyam Jaishankar, the Union Minister of External Affairs, has touted India’s role as ‘pharmacy of the world’. Jaishankar highlighted the country’s role in exporting vital medicines and equipment, amidst the country’s growing role as an exporter of vaccines against COVID-19. “India could meet the spiking requirements of hydroxychloroquine, paracetamol and other relevant drugs across the …
Pharmacy of the world: Jaishankar touts India’s role in global medical supply Read More »
The global vaccination campaign against COVID-19 is scaling up. However, the vaccine drive continues to miss out many countries. Since the vaccine drive commenced in December, more than 345 million vaccine doses have been administered. India began its own vaccine drive in January and, as of Sunday, has administered 29.74 million doses. 24.31 million people …
Global vaccine drive scaling up, but inequities remain Read More »
India’s COVID-19 vaccination campaign has scaled up substantially in the last two days, a boon in the fight against the pandemic. Wednesday saw almost ten lakh shots administered and Thursday almost eleven lakh given out. This marks a significant increase from the recent average of approximately five lakh doses given out a day. The uptick …
Covaxin, India’s homegrown COVID-19 vaccine candidate, has shown promising results in interim phase-III trials. The vaccine, manufactured by Hyderabad, Telangana-headquartered firm Bharat Biotech, demonstrated an almost 81 percent interim clinical efficacy according to the company following the release of results from the interim phase-III trials on Wednesday. “Covaxin demonstrates high clinical efficacy trend against COVID-19 …
Health Issues India is a web portal that tracks key health stories and issues in India. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues India | All rights reserved.
